Compare different amoxicillin schedules for Lyme rash
Part of Mouth & dental clinical trials.
This trial tests which schedule of amoxicillin works best for people who have the early Lyme rash called erythema migrans. It may help you choose a treatment plan that clears infection with fewer issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have the Lyme skin rash called erythema migrans
- You are not pregnant
- You do not have signs of Lyme disease outside the skin (no extracutaneous manifestations)
- You are not immunocompromised (your immune system is not weakened)
- You have not had a serious allergic reaction to beta-lactam antibiotics like amoxicillin
- You have not taken an antibiotic that works against Lyme bacteria in the last 10 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people diagnosed with early Lyme disease (erythema migrans) to learn how people’s expectations about symptoms may affect what happens after treatment. Your experience and beliefs will be compared to see if they relate to post-Lyme symptoms.
This study looks at how long to take doxycycline for people who have multiple early Lyme disease skin rashes. It may help find the shortest effective treatment duration while keeping side effects low.
This trial tests if a probiotic (Saccharomyces boulardii) can help maintain healthy gut bacteria while you take antibiotics for the early skin rash of Lyme disease (erythema migrans). You'll take amoxicillin for 14 days, plus either the probiotic or a placebo.
This study looks at blood antibody test results in adults who may have tick-borne encephalitis and also signs of Lyme disease. It may help researchers understand how these infections relate and which lab patterns fit different illnesses.
This trial compares a short course of amoxicillin (5 days) to the standard longer course (10 days) for erysipelas, a skin infection of the lower legs. It aims to see if the shorter treatment works just as well, with fewer side effects.
This study looks at how your immune system responds to the bacteria that causes Lyme disease. It may help doctors better understand the disease and improve treatment. The trial includes people with a specific form of Lyme called acrodermatitis chronica atrophicans (a skin condition) and healthy volunteers.
Hear when a new Erythema Migrans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.